National Cancer Institute; Notice of Closed Meetings, 57946 [2014-22892]
Download as PDF
<![CDATA[
57946
Federal Register / Vol. 79, No. 187 / Friday, September 26, 2014 / Notices
48. Joan Rosof, Lafayette, Colorado,
Court of Federal Claims No: 14–
0766V
49. Jennifer Ratterman, Newport,
Kentucky, Court of Federal Claims
No: 14–0767V
50. Patty Ferraro on behalf of A.F.,
Venice, Florida, Court of Federal
Claims No: 14–0770V
51. Kenneth Shores, Grants Pass,
Oregon, Court of Federal Claims No:
14–0771V
52. Timothy Steinruck on behalf of
E.J.S., Deceased, Amherst, New
Hampshire, Court of Federal Claims
No: 14–0772V
53. Genice Jarman, Naples, Florida,
Court of Federal Claims No: 14–
0773V
54. Wiley Terry, Sarasota, Florida, Court
of Federal Claims No: 14–0774V
55. Jill Buchignani-Calwhite, Tampa,
Florida, Court of Federal Claims No:
14–0775V
56. Jamie Rothstein, Philadelphia,
Pennsylvania, Court of Federal
Claims No: 14–0778V
57. Jaswinder Singh, Carlsbad,
California, Court of Federal Claims
No: 14–0779V
58. Richard J. Michel, Phillipsburg, New
Jersey, Court of Federal Claims No:
14–0781V
59. Kristin Lintz, Bloomington, Indiana,
Court of Federal Claims No: 14–
0784V
60. Cynthia Hamilton and Robert
Hamilton on behalf of R.M.H., New
York, New York, Court of Federal
Claims No: 14–0785V
61. Cheryl Simmons, Wilmington,
Delaware, Court of Federal Claims
No: 14–0788V
62. Michelene Falsini, Salem, New
Hampshire, Court of Federal Claims
No: 14–0789V
63. Michael McCollum, Seaside,
California, Court of Federal Claims
No: 14–0790V
64. Linda Heeg, Marshfield, Wisconsin,
Court of Federal Claims No: 14–
0795V
65. Jacqueline Freeman, Lexington,
North Carolina, Court of Federal
Claims No: 14–0796V
[FR Doc. 2014–23026 Filed 9–25–14; 8:45 am]
BILLING CODE 4165–15–P
mstockstill on DSK4VPTVN1PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
VerDate Sep<11>2014
19:14 Sep 25, 2014
Jkt 232001
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; R13
Conference Grant Review.
Date: October 30, 2014.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W556, Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Bratin K. Saha, Ph.D.,
Scientific Review Officer, Program
Coordination and Referral Branch, Division
of Extramural Activities, National Cancer
Institute, 9609 Medical Center Drive, Room
7W556, Rockville, MD 20850, 240–276–6411,
sahab@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Omnibus
SEP–1.
Date: November 4–5, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Bethesda, 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Zhiqiang Zou, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, 9609 Medical
Center Drive, Room 7W242, Bethesda, MD
20892–9750, 240–276–6372, zouzhiq@
mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Training
and Career Development Application
Review.
Date: December 3, 2014.
Time: 2:00 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W110, Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Robert Bird, Ph.D., Chief,
Scientific Review Officer, Resources and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
7W110, Bethesda, MD 20892, 240–276–6344,
birdr@mail.nih.gov.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/sep/sep.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: September 22, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–22892 Filed 9–25–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Heart, Lung, and
Blood Initial Review Group; NHLBI
Mentored Patient-Oriented Research Review
Committee.
Date: October 22–23, 2014.
Time: 8:30 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel and
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Stephanie Johnson Webb,
Ph.D., Scientific Review Officer, Office of
Scientific Review/DERA, National Heart,
Lung, and Blood Institute, 6701 Rockledge
Drive, Room 7196, Bethesda, MD 20892, 301–
435–0291, stephanie.webb@nih.gov.
Name of Committee: Heart, Lung, and
Blood Initial Review Group; NHLBI
Mentored Clinical and Basic Science Review
Committee.
Date: October 23–24, 2014.
Time: 10:30 a.m. to 11:00 a.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Crystal City, Arlington, VA
22202.
Contact Person: Keith A. Mintzer, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
E:\FR\FM\26SEN1.SGM
26SEN1
]]>Agencies
[Federal Register Volume 79, Number 187 (Friday, September 26, 2014)]
[Notices]
[Page 57946]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-22892]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; R13 Conference Grant Review.
Date: October 30, 2014.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W556, Rockville, MD 20850, (Telephone Conference
Call).
Contact Person: Bratin K. Saha, Ph.D., Scientific Review
Officer, Program Coordination and Referral Branch, Division of
Extramural Activities, National Cancer Institute, 9609 Medical
Center Drive, Room 7W556, Rockville, MD 20850, 240-276-6411,
sahab@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Omnibus SEP-1.
Date: November 4-5, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Doubletree Hotel Bethesda, 8120 Wisconsin Avenue,
Bethesda, MD 20814.
Contact Person: Zhiqiang Zou, Ph.D., Scientific Review Officer,
Special Review Branch, Division of Extramural Activities, National
Cancer Institute, 9609 Medical Center Drive, Room 7W242, Bethesda,
MD 20892-9750, 240-276-6372, zouzhiq@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Training and Career Development Application Review.
Date: December 3, 2014.
Time: 2:00 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W110, Rockville, MD 20850, (Telephone Conference
Call).
Contact Person: Robert Bird, Ph.D., Chief, Scientific Review
Officer, Resources and Training Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, 7W110, Bethesda, MD 20892, 240-276-6344,
birdr@mail.nih.gov.
Information is also available on the Institute's/Center's home
page: https://deainfo.nci.nih.gov/advisory/sep/sep.htm, where an
agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: September 22, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-22892 Filed 9-25-14; 8:45 am]
BILLING CODE 4140-01-P
